You Position: Home > Paper

A 96-week antiviral therapy for patients with HBV-related cirrhosis

( views:297, downloads:112 )
Author:
No author available
Journal Title:
CHINESE JOURNAL OF CLINICAL INFECTIOUS DISEASES
Issue:
4
DOI:
10.3760/cma.j.issn.1674-2397.2010.04.014
Key Word:
肝硬化;肝炎病毒,乙型;核苷(酸)类似物;病毒变异;Liver cirrhosis;Hepatitis B virus;Nucleoside analogues;Virus mutation

Abstract: @@ 在我国,慢性乙型肝炎是导致肝硬化最常见的原因.已有研究表明,HBV复制活跃的乙型肝炎肝硬化患者更容易发生肝功能衰竭和(或)原发性肝细胞癌,而抗病毒治疗抑制HBV复制是控制病情进展的关键[1].为了评价核苷(酸)类似物治疗乙型肝炎肝硬化的效果和安全性,本研究对乙型肝炎肝硬化患者的治疗情况进行了观察.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn